Speed
69 days to first decision for reviewed manuscripts only
53 days to first decision for all manuscripts
128 days from submission to acceptance
15 days from acceptance to publication

Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.
The field of radiation oncology covers the integration of radiation therapy into multimodal treatment approaches. Radiation Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest research and advances in the field. Advances in treatment technology, as well as improved understanding of the underlying biological resistance mechanisms, will further strengthen the role of radiation oncology.

Case report
Commentary
Letter to the Editor
Methodology
Research
Review
Short report
Study protocol

Editor-in-Chief
Prof Claus Belka, Ludwig Maximilian University of Munich, Germany

Deputy Editor
Dr Kevin Camphausen, National Cancer Institute – Bethesda Radiation Oncology Branch, USA

Managing Editors
Prof Filippo Alongi, Cancer Care Center Sacro Cuore-Don Calabria, Italy
Dr Nicolaus Andratschke, University Hospital of Zurich, Switzerland
Assoc. Prof Stefano Arcangeli, University of Milano-Bicocca, Italy
Prof Michael Atkinson, Helmholtz Zentrum München, Germany
Dr Stefanie Corradini, Ludwig Maximilian University of Munich, Germany
Dr Luca Cozzi, Humanitas Cancer Center, Italy
Dr Andrea Filippi, University of Torino, Italy
Prof Michael Fix, University Hospital Bern, Switzerland
Prof Pirus Ghadjar, Charité Universitätsmedizin Berlin, Germany
Prof Kirsten Lauber, Ludwig Maximilian University of Munich, Germany
Dr Peter Manser, University Hospital Bern, Switzerland
Assoc. Prof Giuseppe Minniti, UPMC Hillman Cancer Center, Italy
Dr Silke Nachbichler, Ludwig Maximilian University of Munich, Germany
Prof Katia Parodi, Ludwig Maximilian University of Munich, Germany
Dr Falk Roeder, Ludwig Maximilian University of Munich, Germany
Prof Horst Zitzelsberger, Helmholtz Zentrum München, Germany

Editorial Board
Prof Markus Alber, University Hospital of Tübingen, Germany
Prof David Azria, Institute of Cancer Research of Montpellier, France
Prof Peter Bartenstein, Ludwig Maximilian University of Munich, Germany
Prof Andy Beavis, Queens Centre for Oncology & Haematology, UK
Dr Christoph Bert, University of Erlangen, Germany
Prof Wilfried Budach, University Hospital of Düsseldorf, Germany
Dr Arnab Chakravarti, The Ohio State University, USA
Dr Deborah Citrin, National Cancer Institute, USA
Prof Peter Daniel, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Germany
Prof Dirk De Ruysscher, Maastricht University Medical Centre, Netherlands
Prof Jürgen Debus, University Hospital Heidelberg, Germany
Dr Adam Dicker, Thomas Jefferson University, USA
Dr Claudio Fiorino, University of Milan, Italy
Asst. Prof Gabriel Paiva Fonseca, University of Maastricht, Netherlands
Dr Silvia Formenti, Weill Cornell Medicine, USA
Dr Anna Friedl, Technical University of Munich, Germany
Dr Ute Ganswindt, Ludwig Maximilian University of Munich, Germany
Prof. Guillaume Landry, Medical Center of the University of Munich, Germany
Dr Jose Luis Lopez Guerra, Hospital de l'Esperança, Spain
Prof Erich Gulbins, University of Duisburg-Essen, Germany
Dr Stephen Hahn, MD Anderson Cancer Center, USA
Dr Peter Huber, German Cancer Research Center (DKFZ), Germany
Prof Georges Iliakis, Essen University Hospital, Germany
Prof Verena Jendrossek, Institute of Cell Biology, University of Bern, Switzerland
Dr Florian Kamp, Ludwig Maximilian University of Munich, Germany
Prof Rolf-Dieter Kortmann, University Hospital of Leipzig, Germany
Dr. Christopher Kurz, Ludwig Maximilian University of Munich, Germany
Dr Guido Lammering, Maastricht University, Netherlands
Prof Pedro Lara, University of Munich, Germany
Dr Wolfram Laub, Legacy Health System, USA
Prof Frank Lohr, University of Heidelberg, Germany
Dr Cynthia Menard, University of Toronto, Canada
Prof Maximilian Niyazi, Ludwig Maximilian University of Munich, Germany
Dr Andrea Ng, Brigham & Women’s Hospital, USA
Prof Uwe Oelfke, German Cancer Research Center (DKFZ), Germany
Prof Esat-Mahmut Ozsahin, University Hospital of Lausanne, Switzerland
Dr Anussara Prayongrat, King Chulalongkorn Memorial Hospital, Thailand
Prof Martin Pruschy, University Hospital of Zurich, Switzerland
Prof Coen Rasch, The Netherlands Cancer Institute, Netherlands
Dr Claus Rödel, Goethe University Frankfurt, Germany
Prof Uwe Schneider, University of Zurich, Switzerland
Prof Suresh Senan, VU University Amsterdam, Netherlands
Prof Alphonse Taghian, Massachusetts General Hospital, USA
Prof Beate Timmermann, University of Duisburg-Essen, Germany
Prof Dirk Verellen, UZ Brussels, Belgium
Prof Marcel Verheij, Netherlands Cancer Institute, Netherlands
Prof Dirk Vordermark, University Hospital Halle (Saale), Germany
Prof Wolfgang Wick, University Hospital Heidelberg, Germany
Dr Ting Xu, MD Anderson Cancer Center, USA
Dr Jinbo Yue, Shandong Cancer Hospital and Institute, China
Prof Boris Zhivotovsky, Karolinska Institute, Sweden
Dr Sebastian Zschaeck, Charité Universitätsmedizin Berlin, Germany